J&J’s Aciphex Prescriptions May Be Feeling Effects Of Prilosec OTC Launch
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson says it is premature to determine whether sales of its prescription proton pump inhibitor Aciphex (rabeprazole 20 mg) have been negatively impacted by the September launch of Procter & Gamble's Prilosec OTC